The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $153.56

Today's change+0.72 +0.47%
Updated November 22 11:37 AM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $153.56

Today's change+0.72 +0.47%
Updated November 22 11:37 AM EST. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings up (U.S.)$0.72

Laboratory Corporation of America Holdings is up today by (U.S.)$0.72 or 0.47% to (U.S.)$153.56. Over the last five days, shares have gained 2.81% and 19.61% year to date. Shares have outperformed the S&P 500 by 5.23% during the last year.

Key company metrics

  • Open(U.S.) $152.82
  • Previous close(U.S.) $152.84
  • High(U.S.) $153.75
  • Low(U.S.) $152.43
  • Bid / Ask(U.S.) $153.52 / (U.S.) $153.60
  • YTD % change+19.61%
  • Volume117,181
  • Average volume (10-day)620,764
  • Average volume (1-month)678,145
  • Average volume (3-month)656,964
  • 52-week range(U.S.) $123.36 to (U.S.) $164.22
  • Beta0.88
  • Trailing P/E21.43×
  • P/E 1 year forward16.04×
  • Forward PEG1.69×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $7.17
Updated November 22 11:37 AM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.44%

Based on its net profit margin of 7.44%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.03%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue2,6552,5432,4472,428
Total other revenue--------
Total revenue2,6552,5432,4472,428
Gross profit883862804788
Total cost of revenue1,7721,6811,6431,640
Total operating expense2,3142,2072,1142,105
Selling / general / administrative465435419406
Research & development--------
Depreciation / amortization55514849
Interest expense (income), net operating--------
Unusual expense (income)2239410
Other operating expenses, total--------
Operating income341336333323
Interest income (expense), net non-operating-60-55-52-53
Gain (loss) on sale of assets--------
Other--------
Income before tax281285280277
Income after tax183189193185
Income tax, total98968792
Net income181189192184
Total adjustments to net income--------
Net income before extra. items181189192184
Minority interest-3000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items181189192184
Inc. avail. to common incl. extra. items181189192184
Diluted net income181189192184
Dilution adjustment--------
Diluted weighted average shares104104104105
Diluted EPS excluding extraordinary itemsvalue per share1.741.821.841.76
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.882.071.871.83